Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

CYCLOPHOSPHAMIDE

CYCLOPHOSPHAMIDE

Standard Dose
500MG/2.5ML (200MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview CYCLOPHOSPHAMIDE is listed in Drugs@FDA under application 217651 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient CYCLOPHOSPHAMIDE Form and strength SOLUTION;INTRAVENOUS - 500MG/2.5ML (200MG/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2023-06-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview CYCLOPHOSPHAMIDE is listed in Drugs@FDA under application 217651 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CYCLOPHOSPHAMIDE Form and strength SOLUTION;INTRAVENOUS - 500MG/2.5ML (200MG/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2023-06-27 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.